US2007032639A1PendingUtilityA1
Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation
Est. expiryFeb 1, 2021(expired)· nominal 20-yr term from priority
C07K 14/245C12N 15/11
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation.
Claims
exact text as granted — not AI-modified1 . An isolated polynucleotide comprising Candidate #8, or its complement, or its homolog having at least about 95% identity thereto.
2 . An isolated polynucleotide comprising Candidate #12, or its complement, or its homolog having at least about 95% identity thereto.
3 . An isolated polynucleotide comprising Candidate #14, or its complement, or its homolog having at least about 95% identity thereto.
4 . An isolated polynucleotide comprising Candidate #22, or its complement, or its homolog having at least about 95% identity thereto.
5 . An isolated polynucleotide comprising Candidate #24, or its complement, or its homolog having at least about 95% identity thereto.
6 . An isolated polynucleotide comprising Candidate #25, or its complement, or its homolog having at least about 95% identity thereto.
7 . An isolated polynucleotide comprising Candidate #26, or its complement, or its homolog having at least about 95% identity thereto.
8 . An isolated polynucleotide comprising Candidate #27, or its complement, or its homolog having at least about 95% identity thereto.
9 . An isolated polynucleotide comprising Candidate #31, or its complement, or its homolog having at least about 95% identity thereto.
10 . An isolated polynucleotide comprising Candidate #38, or its complement, or its homolog having at least about 95% identity thereto.
11 . An isolated polynucleotide comprising Candidate #40, or its complement, or its homolog having at least about 95% identity thereto.
12 . An isolated polynucleotide comprising Candidate #41-I, or its complement, or its homolog having at least about 95% identity thereto.
13 . An isolated polynucleotide comprising Candidate #41-II, or its complement, or its homolog having at least about 95% identity thereto.
14 . An isolated polynucleotide comprising Candidate #43, or its complement, or its homolog having at least about 95% identity thereto.
15 . An isolated polynucleotide comprising Candidate #52-I, or its complement, or its homolog having at least about 95% identity thereto.
16 . An isolated polynucleotide comprising Candidate #52-II, or its complement, or its homolog having at least about 95% identity thereto.
17 . An isolated polynucleotide comprising Candidate #55-I, or its complement, or its homolog having at least about 95% identity thereto.
18 . An isolated polynucleotide comprising Candidate #55-II, or its complement, or its homolog having at least about 95% identity thereto.
19 . An isolated polynucleotide comprising Candidate #61, or its complement, or its homolog having at least about 95% identity thereto.
20 . An isolated polynucleotide comprising Candidate #9, or its complement, or its homolog having at least about 95% identity thereto.
21 . An isolated polynucleotide comprising Candidate #17, or its complement, or its homolog having at least about 95% identity thereto.
22 . An isolated polynucleotide comprising Candidate #28, or its complement, or its homolog having at least about 95% identity thereto.
23 . An isolated polynucleotide comprising Candidate #36, or its complement, or its homolog having at least about 95% identity thereto.
24 . An isolated polynucleotide comprising Candidate #49, or its complement, or its homolog having at least about 95% identity thereto.
25 . An isolated polynucleotide comprising Candidate #50, or its complement, or its homolog having at least about 95% identity thereto.
26 .- 56 . (canceled)Join the waitlist — get patent alerts
Track US2007032639A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.